GlaxoSmithKline Pakistan : Transmission of Annual Report for the Year Ended December 31, 2022
CONTENTS Organisational Overview and Business Environment Purpose, Strategy and Culture ... | May 3, 2023
Source: marketscreener.com
Stay updated with breaking news from Looking Disclosures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONTENTS Organisational Overview and Business Environment Purpose, Strategy and Culture ... | May 3, 2023
Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage pharmaceutical company with a focus on dermatology, today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical